Abstract
Renal cell carcinoma is the common name applied to adenocarcinoma of the kidney, a tumor arising in the renal cortex and accounting for approximately 85% of malignancies of the kidney (1). Kidney cancer is the third most common malignancy of the urinary tract, after prostate cancer and bladder cancer. The American Cancer Society estimates that there will be 30,000 new cases and 11,900 deaths from kidney cancer in the United States in 1999 (2). The incidence of renal cell carcinoma was previously reported to have increased about 35% over the past two decades, with slightly decreased mortality rates (1). A more recent analysis, however, confirmed the increased incidence rates between 1975 and 1995, but also reported an increase in mortality rates for all race and sex groups (3). Both reports postulated that the increased incidence rates reflect earlier diagnosis at a earlier (and more treatable) stage, largely caused by more frequent and liberal use of modern radiological imaging techniques. Nonetheless, this tumor is still commonly diagnosed late because it is characterized by few symptoms and signs directly related to the renal primary site. It has been called the “internist’s tumor” because of its associated systemic effects. In the past, up to 40% of patients already had metastases when the initial diagnosis was made, but this figure does not reflect the contemporary increase in tumors diagnosed incidentally. The median age at presentation is 65 yr, and the ratio of men to women with kidney cancer is approximately three to two (17,800 to 12,200 in 1999, as estimated by the American Cancer Society) (1,2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kosary CL and McLaughlin JK. Kidney and renal pelvis. In SEER Cancer Statistics Review, 1973– 1990. Miller BA, Ries LAG, and Hankey BF, et al. (eds.), National Cancer Institute, Bethesda, MD, 1993.
Landis SH, Murray T, Bolden S, and Wingo PA. Cancer statistics, 1999, CA Cancer J. Clin., 49 (1999) 8–31.
Chow W-H, Devesa SS, Warren JL, and Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States, JAMA, 281 (1999) 1628–1631.
Thompson IM and Peek M. Improvement in survival of patients with renal cell carcinoma: the role of the serendipitously detected tumor, J. Urol., 140 (1988) 487–490.
Smith SJ, Bosniak MA, Megibow AJ, Hulnick DH, Horii SC, and Raghavendra BN. Renal cell carcinoma: earlier discovery and increased detection, Radiology, 170 (3 Pt 1) (1989) 699–703.
Amendola MA, Bree RL, Pollack HM, Francis IR, Glazer GM, Jafri SZH, et al. Small renal cell carcinomas: resolving a diagnostic dilemma, Radiology, 166 (1988) 637–641.
Ritchie AWS and Chisholm GD. The natural history of renal carcinoma, Semin. Oncol., 10 (1983) 390–400.
Holland JM. Cancer of the kidney: natural history and staging, Cancer, 5 (1973) 1030–1042.
Gibbons RP, Montie JE, Correa RJ Jr, and Mason JT. Manifestations of renal cell carcinoma, Urology, 8 (1976) 201–206.
Riches EW, Griffiths IH, and Thackray AC. New growths of the kidney and ureter, Br. J. Urol., 23 (1951) 297–311.
Clayman RV, Gonzalez R, and Fraley EE. Renal cell cancer invading the inferior vena cava: clinical review and anatomical approach, J. Urol., 123 (1980) 157–163.
Pritchett TR, Lieskovsky G, and Skinner DG. Extension of renal cell carcinoma into the vena cava: clinical review and surgical approach, J. Urol., 135 (1986) 460–464.
Kovacs G. Molecular cytogenetics of renal cell tumors, Adv. Cancer Res., 62 (1993) 89–124.
Ball DS, Friedman AC, Hartman DS, Radecki PD, and Caroline DF. Scar sign of renal oncocytoma: magnetic resonance imaging appearance and lack of specificity, Urol. Radiol., 8 (1986) 46–48.
Davidson AJ, Hayes WS, Hartman DS, McCarthy WF, and Davis CJ Jr. Renal oncocytoma and carcinoma: failure of differentiation with CT, Radiology, 186 (1993) 693–696.
Bosniak MA. Angiomyolipoma (hamartoma) of the kidney: a preoperative diagnosis is possible in virtually every case, Urol. Radiol., 3 (1981) 135–142.
Helenon O, Chretien Y, Paraf F, Melki P, Denys A, and Moreau JF. Renal cell carcinoma containing fat: demonstration with CT, Radiology, 188 (1993) 429–430.
Strotzer M, Lehner KB, and Becker K. Detection of fat in a renal cell carcinoma mimicking angiomyolipoma, Radiology, 188 (1993) 427, 428.
Huang JK, Ho DM, Wang JH, Chou YH, Chen MT, and Chang SS. Coincidental angiomyolipoma and renal cell carcinoma: report of 1 case and review of literature, J. Urol., 140 (1988) 1516–1518.
Ueda J, Kobayashi Y, Itoh H, and Itatani H. Angiomyolipoma and renal cell carcinoma occurring in same kidney: CT evaluation, J. Comput. Assist. Tomogr., 11 (1987) 340, 341.
Sheeran SR and Sussman SK. Renal lymphoma: spectrum of CT findings and potential mimics, AJR, 171 (1998) 1067–1072.
Cohan RH, Dunnick NR, Leder RA, and Baker ME. Computed tomography of renal lymphoma, J. Comput. Assist. Tomogr., 14 (1990) 933–938.
Bennington JL and Beckwith JB. Tumors of the kidney, renal pelvis, and ureter. Washington (DC): Armed Forces Institute of Pathology (US); 1975. Atlas of Tumor Pathology, Second Series, Fascicle 12.
Choyke PL, White EM, Zeman RK, Jaffe MH, and Clark LR. Renal metastases: clinicopathologic and radiologic correlation, Radiology, 162 (1987) 359–363.
Blacher E, Johnson DE, and Haynie TP. Value of routine radionuclide bone scans in renal cell carcinoma, Urology, 26 (1985) 432–434.
Benson MA, Haaga JR, and Resnick MI. Staging renal carcinoma. What is sufficient? Arch. Surg., 124 (1989) 71–73.
Swanson DA and Bernardino ME. “Silent” osseous metastases in renal cell carcinoma: value of computerized tomography, Urology, 20 (1982) 208–212.
Bechtold RE and Zagoria RJ. Imaging approach to staging of renal cell carcinoma, Urol. Clin. North Am., 24 (1997) 507–522.
Daniel WW Jr, Hartman GW, Witten DM, Farrow GM, and Kelalis PP. Calcified renal masses: a review of ten years experience at the Mayo clinic, Radiology, 103 (1972) 503–508.
Warshauer DM, McCarthy SM, Street L, Bookbinder MJ, Glickman MG, Richter J, et al. Detection of renal masses: sensitivities and specificities of excretory urography/linear tomography, US, and CT, Radiology, 169 (1988) 363–365.
Bosniak MA. The current radiological approach to renal cysts, Radiology, 158 (1986) 1–10.
Habboub HK, Abu-Yousef MM, Williams RD, See WA, and Schweiger GD. Accuracy of color Doppler sonography in assessing venous thrombus extension in renal cell carcinoma, AJR, 168 (1997) 267–271.
Gilbert BR, Russo P, Zirinsky K, Kazam E, Fair WR, and Vaughan ED Jr. Intraoperative sonography: application in renal cell carcinoma, J. Urol., 139 (1988) 582–584.
Assimos DG, Boyce WH, Woodruff RD, Harrison LH, McCullough DL, and Kroovand RL. Intraoperative renal ultrasonography: a useful adjunct to partial nephrectomy, J. Urol., 146 (1991) 1218–1220.
Walther MM, Choyke PL, Hayes W, Shawker TH, Alexander RB, and Linehan WM. Evaluation of color Doppler intraoperative ultrasound in parenchymal sparing renal surgery, J. Urol., 152 (1994) 1984–1987.
Polascik TJ, Meng MV, Epstein JI, and Marshall FF. Intraoperative sonography for the evaluation and management of renal tumors: experience with 100 patients, J. Urol., 154 (1995) 1676–1680.
Long JP, Choyke PL, Shawker TA, Robertson CA, Pass HI, Walther MM, et al. Intraoperative ultrasound in the evaluation of tumor involvement of the inferior vena cava, J. Urol., 150 (1993) 13–17.
Treiger BFG, Humphrey LS, Peterson CV Jr, Oesterling JE, Mostwin JL, Reitz BA, et al. Transesophageal echocardiography in renal cell carcinoma: an accurate diagnostic technique for intracaval neoplastic extension, J. Urol., 145 (1991) 1138–1140.
Weyman PJ, McClennan BL, Stanley RJ, Levitt RG, and Sagel SS. Comparison of computed tomography and angiography in the evaluation of renal cell carcinoma, Radiology, 137 (1980) 417–424.
Chernoff DM, Silverman SG, Kikinis R, Adams DF, Seltzer SE, Richie JP, et al. Three-dimensional imaging and display of renal tumors using spiral CT: a potential aid to partial nephrectomy, Urology, 43 (1994) 125–129.
Coll DM, Uzzo RG, Herts BR, Davros WJ, Wirth SL, and Novick AC. 3-dimensional volume rendered computerized tomography for preoperative evaluation and intraoperative treatment of patients undergoing nephron sparing surgery, J. Urol., 161 (1999) 1097–1102.
Novick AC and Cosgrove DM. Surgical approach for removal of renal cell carcinoma extending into the vena cava and the right atrium, J. Urol., 123 (1980) 947–950.
Klein EA, Kaye MC, and Novick AC. Management of renal cell carcinoma with vena caval thrombi via cardiopulmonary bypass and deep hypothermic circulatory arrest, Urol. Clin. North Am., 15 (1991) 445–447.
Horan JJ, Robertson CN, Choyke PL, Frank JA, Miller DL, Pass HI, et al. The detection of renal carcinoma extension into the renal vein and inferior vena cava: a prospective comparison of venacavography and magnetic resonance imaging, J. Urol., 142 (1989) 943–948.
Arrivé L, Menu Y, Dessarts I, Dubray B, Vullierme MP, Vilgrain V, et al. Diagnosis of abdominal venous thrombosis by means of spin-echo and gradient-echo MR imaging: analysis with receiver operating characteristic curves, Radiology, 181 (1991) 661–668.
Oto A, Herts BR, Remer EM, and Novick AC. Inferior vena cava tumor thrombus in renal cell carcinoma: staging by MR imaging and impact on surgical treatment, AJR, 171 (1998) 1619–1624.
Silverman SG, Lee BY, Seltzer SE, Bloom DA, Corless CL, and Adams DF. Small (< 3 cm) renal masses: correlation of spiral CT features and pathologic findings, AJR, 163 (1994) 597–605.
Szolar DH, Kammerhuber F, Altziebler S, Tillich M, Breinl E, Fotter R, et al. Multiphasic helical CT of the kidney: increased conspicuity for detection and characterization of small (lt; 3-cm) renal masses, Radiology, 202 (1997) 211–217.
London NJ, Messios N, Kinder RB, Smart JG, Osborn DE, Watkin EM, et al. A prospective study of the value of conventional CT, dynamic CT, ultrasonography and arteriography for staging renal carcinoma, Br. J. Urol., 64 (1989) 209–217.
Cloix P, Martin X, Pangaud C, Maréchal J-M, Bouvier R, Barat D, et al. Surgical management of complex renal cysts: a series of 32 cases, J. Urol., 156 (1996) 28–30.
Siegel CL, McFarland EG, Brink JA, Fisher AJ, Humphrey P, and Heiken JP. CT of cystic renal masses: analysis of diagnostic performance and interobserver variation, AJR, 169 (1997) 813–818.
Wolf JS Jr. Evaluation and management of solid and cystic renal masses, J. Urol., 159 (1998) 1120–1133.
Bosniak MA. Difficulties in classifying cystic lesions of the kidney, Urol. Radiol., 13 (1991) 91–93.
Bosniak MA. The use of the Bosniak classification system for renal cysts and cystic tumors [editorial], J. Urol., 157 (1997) 1852, 1853.
Aronson S, Frazier HA, Baluch JD, Hartman DS, and Christenson PJ. Cystic renal masses: usefulness of the Bosniak classification, Urol. Radiol., 13 (1991) 83–90.
Studer UE, Scherz S, Scheidegger J, Kraft R, Sonntag R, Ackermann D, et al. Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases, J. Urol., 144 (1990) 243–245.
Kreft BP, Muller-Miny H, Sommer T, Steudel A, Vahlensieck M, Novak D, et al. Diagnostic value of MR imaging in comparison to CT in the detection and differential diagnosis of renal masses: ROC analysis, Eur. Radiol., 7 (1997) 542–547.
Kramer LA. Magnetic resonance imaging of renal masses, World J. Urol., 16 (1998) 22–28.
Rofsky NM, Weinreb JC, Bosniak MA, Libes RB, and Birnbaum BA. Renal lesion characterization with gadolinium-enhanced MR imaging: efficacy and safety in patients with renal insufficiency, Radiology, 180 (1991) 85–89.
Semelka RC, Shoenut JP, Kroeker MA, MacMahon RG, and Greenberg HM. Renal lesions: controlled comparison between CT and 1.5-T MR imaging with nonenhanced and gadolinium-enhanced fat-suppressed spin-echo and breath-hold FLASH techniques, Radiology, 182 (1992) 425–4230.
Hricak H, Thoeni RF, Carroll PR, Demas BE, Marotti M, and Tanagho EA. Detection and staging of renal neoplasms: a reassessment of MR imaging, Radiology, 166 (1988) 643–649.
Goldberg MA, Mayo-Smith WW, Papanicolaou N, Fischman AJ, and Lee MJ. FDG PET characterization of renal masses: preliminary experience, Clin. Radiol., 52 (1997) 510–515.
Hoh CK, Seltzer MA, Franklin J, deKernion JB, Phelps, ME, and Belldegrun A. Positron emission tomography in urological oncology, J. Urol., 159 (1998) 347–356.
Bachor R, Kotzerke J, Gottfried HW, Brandle E, Reske SN, and Hautmann R. [Positron emission tonography in diagnosis of renal cell carcinoma], Urologe A, 35 (1996) 146–150.
Miyauchi I, Brown RS, Grossman HB, Wojno K, and Wahl RL. Correlation between visualization of primary renal cancer by FDG-PET and histopathological findings [abstract], J. Nucl. Med., 37 (5 Suppl) (1996) 64.
Hoh CK, Figlin RA, Belldegrun A, Moon DH, Franklin J, Phelps ME, et al. Evaluation of renal cell carcinoma with whole body FDG PET [abstract], J. Nucl. Med., 37 (5 Suppl) (1996) 141.
Mankoff DA, Thompson JA, Gold P, Eary JF, Guinee DG Jr, and Samlowski WE. Identification of interleukin-2-induced complete response in metastatic renal cell carcinoma by FDG PET despite radiographic evidence suggesting persistent tumor, AJR, 169 (1997) 1049, 1050.
Bender H, Schomburg A, Albers P, Ruhlmann J, and Biersack H-J. Possible role of FDG-PET in the evaluation of urologic malignancies, Anticancer Res, 17 (1997) 1655–1660.
Oosterwijk E, Bander NH, Divgi CR, Welt S, Wakka JC, Finn RD, et al. Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250, J. Clin. Oncol., 11 (1993) 738–750.
Flocks RH and Kadesky MC. Malignant neoplasms of the kidney: an analysis of 353 patients followed five years or more, J. Urol., 79 (1958) 196–201.
Robson CJ, Churchill BM, and Anderson W. The results of radical nephrectomy for renal cell carcinoma, J. Urol., 101 (1969) 297–301.
Manual of staging of cancer/American Joint Committee on Cancer. 4th Edition. Lippincott-Raven, Philadelphia, PA, 1992.
Kidney, In AJCC Cancer Staging Manual/American Joint Committee on Cancer. 5th Edition. Lippincott-Raven, Philadelphia, PA, 1997, pp. 231–234.
Guinan PD, Vogelzang NJ, Fremgen AM, Chmiel JS, Sylvester JL, Sener SF, et al. Renal cell carcinoma: tumor size, stage and survival, J. Urol., 153 (1995) 901–903.
Gettman MT, Blute ML, Iocca AJ, and Zincke H. Significance of the 1997 TNM staging system for pathologic classification of renal cell carcinoma [abstract], J. Urol., 161 (4 Suppl) (1999) 193.
Bryant SC, Iocca AJ, Gettman MT, Blute ML, and Zincke H. Staging of T1 versus T2 renal cell carcinoma: the issue of tumor size cutpoint [abstract], J. Urol., 161 (4 Suppl) (1999) 194.
Guinan P, Sobin LH, Algaba F, Badellino F, Kameyama GM, MacLennan G, et al. TNM staging of renal cell carcinoma: workgroup no. 3, Cancer, 80 (1997) 992, 993.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Slaton, J.W., Swanson, D.A. (2000). Renal Cell Carcinoma. In: Bukowski, R.M., Novick, A.C. (eds) Renal Cell Carcinoma. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-229-6_7
Download citation
DOI: https://doi.org/10.1007/978-1-59259-229-6_7
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-6401-7
Online ISBN: 978-1-59259-229-6
eBook Packages: Springer Book Archive